Christopher W Krueger insider trades: Ventyx Biosciences (VTYX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Christopher reports to the SEC
Open-market buys and sales
23 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 2, 2024 | VTYX | ↓ Sell | 1,651 | $5.40 | $9K | Direct | Apr 3, 2024 (1d) |
| Dec 20, 2023 | VTYX | ↓ Sell | 5,293 | $2.12 | $11K | Direct | Dec 21, 2023 (1d) |
| Oct 3, 2023 | VTYX | ↓ Sell | 15,000 | $29.98 | $450K | Direct | Oct 4, 2023 (1d) |
| Sep 5, 2023 | VTYX | ↓ Sell | 15,000 | $32.61 | $489K | Direct | Sep 7, 2023 (2d) |
| Aug 3, 2023 | VTYX | ↓ Sell | 15,000 | $35.59 | $534K | Direct | Aug 4, 2023 (1d) |
| Jul 3, 2023 | VTYX | ↓ Sell | 15,000 | $39.22 | $588K | Direct | Jul 5, 2023 (2d) |
| Jun 5, 2023 | VTYX | ↓ Sell | 15,000 | $34.36 | $515K | Direct | Jun 6, 2023 (1d) |
| May 3, 2023 | VTYX | ↓ Sell | 15,000 | $38.65 | $580K | Direct | May 4, 2023 (1d) |
| Dec 22, 2022 | VTYX | ↓ Sell | 3,654 | $31.61 | $116K | Direct | Dec 23, 2022 (1d) |
| Dec 13, 2022 | VTYX | ↓ Sell | 30,000 | $34.46 | $1.0M | Direct | Dec 15, 2022 (2d) |
| Dec 2, 2022 | VTYX | ↓ Sell | 50,000 | $29.01 | $1.5M | Direct | Dec 6, 2022 (4d) |
| Apr 3, 2022 | VTYX | ↓ Sell | 15,000 | $32.88 | $493K | Direct | Apr 5, 2023 (367d) |
| Jul 23, 2010 | RDEA | ↓ Sell | 3,000 | $18.54 | $56K | Direct | Jul 26, 2010 (3d) |
| Jun 23, 2010 | RDEA | ↓ Sell | 3,000 | $21.93 | $66K | Direct | Jun 24, 2010 (1d) |
| May 24, 2010 | RDEA | ↓ Sell | 3,000 | $22.97 | $69K | Direct | May 26, 2010 (2d) |
| May 17, 2010 | RDEA | ↓ Sell | 1,145 | $23.19 | $27K | Direct | May 18, 2010 (1d) |
| Apr 23, 2010 | RDEA | ↓ Sell | 3,000 | $26.24 | $79K | Direct | Apr 26, 2010 (3d) |
| Mar 23, 2010 | RDEA | ↓ Sell | 9,000 | $18.45 | $166K | Direct | Mar 24, 2010 (1d) |
| Dec 23, 2009 | RDEA | ↓ Sell | 6,000 | $15.11 | $91K | Direct | Dec 24, 2009 (1d) |
| Oct 23, 2009 | RDEA | ↓ Sell | 3,000 | $15.25 | $46K | Direct | Oct 26, 2009 (3d) |
| Sep 23, 2009 | RDEA | ↓ Sell | 3,000 | $18.89 | $57K | Direct | Sep 24, 2009 (1d) |
| Aug 24, 2009 | RDEA | ↓ Sell | 5,061 | $19.00 | $96K | Direct | Aug 25, 2009 (1d) |
| May 20, 2009 | RDEA | ↓ Sell | 27,500 | $15.02 | $413K | Direct | May 21, 2009 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other VTYX insiders
Open-market trades in the last 12 months
About Christopher W Krueger's insider trades
Christopher W Krueger is Chief Business Officer at Ventyx Biosciences (VTYX). Since May 20, 2009, Christopher has reported no open-market purchases and 23 sales worth $7.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (21 filings), grants and awards (8 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VTYX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.